Consonance Capital Management as of Sept. 30, 2013
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 26 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NPS Pharmaceuticals | 10.8 | $43M | 1.4M | 31.81 | |
| United Therapeutics Corporation (UTHR) | 9.2 | $37M | 468k | 78.85 | |
| Furiex Pharmaceuticals | 8.4 | $34M | 762k | 43.99 | |
| Wuxi Pharmatech Cayman Spons Adr Shs | 6.9 | $27M | 1.0M | 27.40 | |
| Medicines Company | 6.2 | $25M | 741k | 33.52 | |
| Affymetrix | 5.3 | $21M | 3.4M | 6.20 | |
| AMAG Pharmaceuticals | 5.1 | $20M | 943k | 21.47 | |
| Taro Pharmaceutical Inds SHS (TARO) | 4.9 | $20M | 260k | 76.00 | |
| Emergent BioSolutions (EBS) | 4.9 | $20M | 1.0M | 19.05 | |
| Salix Pharmaceuticals | 4.8 | $19M | 288k | 66.88 | |
| Cardiovascular Systems | 4.4 | $18M | 878k | 20.05 | |
| Endo Pharmaceuticals | 4.3 | $17M | 380k | 45.44 | |
| Biogen Idec (BIIB) | 3.6 | $14M | 60k | 240.77 | |
| Insys Therapeutics Com New | 3.6 | $14M | 408k | 34.99 | |
| Orthofix International Nv Com Stk | 3.3 | $13M | 643k | 20.77 | |
| Enanta Pharmaceuticals (ENTA) | 3.3 | $13M | 570k | 22.92 | |
| Clovis Oncology | 2.2 | $8.6M | 142k | 60.80 | |
| Anacor Pharmaceuticals In | 2.0 | $7.8M | 738k | 10.62 | |
| Chindex International | 1.5 | $6.0M | 353k | 17.04 | |
| Ariad Pharmaceuticals | 1.4 | $5.6M | 305k | 18.40 | |
| Vanda Pharmaceuticals (VNDA) | 1.4 | $5.6M | 508k | 10.95 | |
| Sucampo Pharmaceuticals Cl A | 1.3 | $5.3M | 855k | 6.24 | |
| Liposcience | 0.6 | $2.2M | 445k | 5.00 | |
| Hyperion Therapeutics | 0.5 | $2.2M | 83k | 26.14 | |
| D Horizon Pharma | 0.1 | $352k | 105k | 3.35 | |
| Celgene Corp Right 12/31/2030 | 0.0 | $111k | 14k | 8.06 |
